ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,130.87
1.32%
US Tech 100
17,434.40
2.10%
다우존스 지수
38,695.98
1.23%
Bitcoin
61,817.34
4.56%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Immuneering Corporation (IMRX)

  7. Immuneering Corporation (IMRX) 뉴스

IMRX Immuneering Corporation

1.64
0.08 (5.13%)
최종 업데이트: 03:36:32
15분 지연
기업명 주식 심볼 시장 주식 타입
Immuneering Corporation IMRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.08 5.13% 1.64 03:36:32
개장가 저가 고가 종가 전일 종가
1.73 1.60 1.73 1.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/04/202401:00GLOBEIMM-1-104 is Synergistic with Chemotherapy in Pancreatic..
04/04/202405:05GLOBEImmuneering to Participate in the 23rd Annual Needham..
27/03/202421:00GLOBEImmuneering Announces First Patient Dosed in its Phase 1/2a..
14/03/202420:00GLOBEImmuneering Announces Positive Topline Results from Phase 1..
12/03/202421:00GLOBEImmuneering Appoints Thomas J. Schall, Ph.D. to its Board of..
11/03/202421:00GLOBEImmuneering Doses First Patient in Phase 2a Clinical Trial..
06/03/202407:00GLOBEImmuneering to Present Preclinical Data on Universal-RAS..
04/03/202422:00GLOBEImmuneering to Participate in the Cowen 44th Annual Health..
01/03/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/03/202422:00GLOBEImmuneering Reports Fourth Quarter and Full Year 2023..
01/03/202421:58EDGAR2Form 8-K - Current report
20/02/202422:00GLOBEImmuneering Receives FDA Fast Track Designation for..
10/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:15EDGAR2Form 8-K - Current report
17/01/202406:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/01/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:00GLOBEImmuneering Announces FDA Clearance of IND Application for..
21/11/202306:05GLOBEImmuneering to Present at the 35th Annual Piper Sandler..
10/11/202306:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:05GLOBEImmuneering Reports Third Quarter 2023 Financial Results and..
13/10/202305:05GLOBEImmuneering Presents Preclinical Data Demonstrating..
05/10/202305:05GLOBEImmuneering to Present Preclinical Data on IMM-1-104 and..
06/09/202321:00GLOBEImmuneering to Present at the Morgan Stanley Healthcare..
04/08/202305:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:05GLOBEImmuneering Reports Second Quarter 2023 Financial Results..
04/08/202305:04EDGAR2Form 8-K - Current report
05/06/202321:00GLOBEImmuneering Completes Dose Escalation in the IMM-1-104 Phase..
30/05/202321:00GLOBEImmuneering to Present at the Jefferies Healthcare..
05/05/202305:05GLOBEImmuneering Reports First Quarter 2023 Financial Results and..

최근 히스토리

NASDAQ
IMRX
Immuneering
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유